Superpower announced a strategic partnership with GRAIL (GRAL) to bring members access to the Galleri multi-cancer early detection test. The Galleri test is available as an add-on through the Superpower platform. The test requires a prescription, is recommended for adults with an elevated risk for cancer such as those aged 50 or older, and should be used in addition to recommended single-cancer screening tests.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRAL: